ClearNote Health Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
49
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$52M
- Investors
-
4
ClearNote Health General Information
Description
Developer of a proprietary epigenomic technology designed to detect high-mortality cancers at an early, more treatable stage through a standard blood draw. The company's technology offers non-invasive, cell-free DNA-based assays that track dynamic biological changes using biomarkers and artificial intelligence, enabling high-risk individuals, such as those with newly diagnosed type 2 diabetes or predisposition to pancreatic and ovarian cancers, to access early detection and improved treatment outcomes.
Contact Information
Website
www.clearnotehealth.comCorporate Office
- 10578 Science Center Drive
- Suite 210
- San Diego, CA 92121
- United States
Corporate Office
- 10578 Science Center Drive
- Suite 210
- San Diego, CA 92121
- United States
ClearNote Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series D) | 27-May-2026 | $52M | Completed | Generating Revenue | ||
| 5. Later Stage VC | Completed | Generating Revenue | ||||
| 4. Later Stage VC (Series C) | 12-May-2021 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | Completed | Generating Revenue | ||||
| 2. Debt - PPP | 15-Apr-2020 | $4.95M | $5M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | $5M | $5M | Completed | Startup |
ClearNote Health Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D-1 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 3,333,332 | $0.000100 | 5% | $3 | $3 | 1x | $3 | 9.84% |
| Series A | 5,000,000 | $0.000100 | 5% | $1 | $1 | 1x | $1 | 14.76% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ClearNote Health Signals
ClearNote Health Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Pathology Asia Holdings | PE-Backed Company | Minority | ||
| Prosperity Capital Management | Hedge Fund | Minority |
ClearNote Health FAQs
-
When was ClearNote Health founded?
ClearNote Health was founded in 2016.
-
Where is ClearNote Health headquartered?
ClearNote Health is headquartered in San Diego, CA.
-
What is the size of ClearNote Health?
ClearNote Health has 49 total employees.
-
What industry is ClearNote Health in?
ClearNote Health’s primary industry is Drug Discovery.
-
Is ClearNote Health a private or public company?
ClearNote Health is a Private company.
-
What is the current valuation of ClearNote Health?
The current valuation of ClearNote Health is .
-
What is ClearNote Health’s current revenue?
The current revenue for ClearNote Health is .
-
How much funding has ClearNote Health raised over time?
ClearNote Health has raised $180M.
-
Who are ClearNote Health’s investors?
, , Pathology Asia Holdings, and Prosperity Capital Management have invested in ClearNote Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process